Startups
Symvivo Corporation is a biotechnology company that develops a novel bacterial-based gene delivery platform technology for the treatment of solid tumors. The company was founded in 2013 and is based in Burnaby, British Columbia. Symvivo’s bacTRL™ platform technology delivers plasmid DNA, both orally and through IV administration, that enables a patient’s own cells to produce biologics. Symvivo is advancing therapeutics in the area of oral vaccines, oncology, immunology, and biologics.
Overview
Location
Canada, British Columbia, Burnaby
Employees
11-50
Total raised
$650K
Founded date
2013
FAQ about Symvivo Corporation
When was Symvivo Corporation founded?
Symvivo Corporation was founded in 2013.
How much funding has Symvivo Corporation raised?
Symvivo Corporation has raised $650K in total across 1 funding round.
Is Symvivo Corporation still active?
Symvivo Corporation is probably closed: its latest activity on Parsers VC dates from Jun 1, 2022.